MilliporeSigma has opened a facility in Mollet des Vallès, Spain dedicated to the manufacture of meglumine, an FDA-approved excipient for pharmaceuticals and a component of medical imaging contrast media.     The facility has been validated by the FDA and is currently the only location in Europe that manufactures meglumine, an amino sugar derived from glucose. As an excipient, meglumine interacts directly with active pharmaceutical ingredients to increase solubility and therefore must meet the...